Cargando…

Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients

Numerous studies have investigated the prognostic role of YKL-40 in breast cancer, but yielded inconsistent results. To derive a more precise evaluation, relevant publications assessing the association between YKL-40 expression and clinical outcome of breast cancer patients were electronically searc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Guoxing, Xiang, Longchao, Sun, Xue, Wang, Xuanbin, Li, Hongliang, Ge, Wei, Cao, Fengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354916/ https://www.ncbi.nlm.nih.gov/pubmed/28036271 http://dx.doi.org/10.18632/oncotarget.14280

Ejemplares similares

Elevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor Prognosis
por: Chen, Jinyu, et al.
Publicado: (2018)

Elevated plasma YKL-40 level is found in the dogs with cancer and is related to poor prognosis
por: Cheng, Kai-Chung, et al.
Publicado: (2019)

Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer
por: Wan, Guoxing, et al.
Publicado: (2019)

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers
por: Shao, R, et al.
Publicado: (2011)

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2020)

High YKL-40 Serum Concentration Is Correlated with Prognosis of Chinese Patients with Breast Cancer
por: Wang, Dong, et al.
Publicado: (2012)

Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer
por: Kim, Steve H, et al.
Publicado: (2007)

Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer
por: De Robertis, Mariangela, et al.
Publicado: (2022)

Glycoprotein YKL-40 Is Elevated and Predicts Disease Severity in Puumala Hantavirus Infection
por: Outinen, Tuula K., et al.
Publicado: (2019)

Independent Predictive Value of Elevated YKL-40 in Ischemic Stroke Prognosis: Findings from a Nationwide Stroke Registry
por: Qin, Haiqiang, et al.
Publicado: (2023)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
por: Wang, Dong, et al.
Publicado: (2012)

Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine
por: Wang, Xuanbin, et al.
Publicado: (2016)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Resveratrol represses YKL-40 expression in human glioma U87 cells
por: Zhang, Wei, et al.
Publicado: (2010)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

YKL-40 in the diagnosis, prediction of prognosis, and platinum sensitivity in serous epithelial ovarian cancer
por: Kahramanoğlu, İlker, et al.
Publicado: (2018)

Elevated serum YKL-40 levels as a diagnostic and prognostic marker in the placenta accreta spectrum
por: Bayramoğlu Tepe, Neslihan, et al.
Publicado: (2022)

YKL-40 tissue expression and plasma levels in patients with ovarian cancer
por: Høgdall, Estrid VS, et al.
Publicado: (2009)

Prognostic Impact of YKL-40 Immunohistochemical Expression in Patients with Colorectal Cancer
por: Oh, Il Hwan, et al.
Publicado: (2021)

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
por: Shao, Rong, et al.
Publicado: (2009)

The effects of YKL-40 on angiogenic potential of HUVECs are partly mediated by syndecan-4
por: Sun, WeiJun, et al.
Publicado: (2021)

Role of breast regression protein-39/YKL-40 in asthma and allergic responses
por: Lee, Chun Geun, et al.
Publicado: (2010)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

YKL‐40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma
por: James, Anna J., et al.
Publicado: (2020)

The Value of Serum YKL-40 and TNF-α in the Diagnosis of Acute ST-Segment Elevation Myocardial Infarction
por: Fang, Caoyang, et al.
Publicado: (2022)

The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review
por: Wang, Xuanbin, et al.
Publicado: (2015)

Serum YKL-40 Level Is Associated with the Chemotherapy Response and Prognosis of Patients with Small Cell Lung Cancer
por: Xu, Chun-Hua, et al.
Publicado: (2014)

YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children
por: Yang, Xingge, et al.
Publicado: (2018)

YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling
por: Lai, Tianwen, et al.
Publicado: (2016)

Plasm YKL-40 Levels Are Associated with Hypertension in Patients with Obstructive Sleep Apnea
por: Li, Kun, et al.
Publicado: (2019)

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
por: Jeet, Varinder, et al.
Publicado: (2014)

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
por: Shao, Rong
Publicado: (2013)

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization
por: Shao, Rong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_btl431o2iuqabls4m210ulfthm